CHR. OLESEN PHARMACEUTICALS A/S: Financial statements 2013
CVR: 32090168
Source: annual report 2013, Danish Business Authority
01/10/2012 – 30/09/2013
CHR. OLESEN PHARMACEUTICALS A/S (CVR 32090168) has filed annual accounts for 2013. In 2013, the company reported a gross profit of EUR 733,894 and a net result of EUR -1,305,001. Equity in the 2013 report amounted to EUR -3,269,755. The company had 2 employees in the financial year.
- Gross Profit
- EUR 733,894
- Profit/Loss
- EUR -1,305,001
- Equity
- EUR -3,269,755
- Total Assets
- EUR 13,364,340
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of December 17, 2013, Allan Ardensø has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of December 17, 2013, Terje Aarbogh has left the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of December 17, 2013, Svend Aage Johansen is registered as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
As of December 17, 2013, Terje Aarbogh has stepped down as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2012.
About CHR. OLESEN PHARMACEUTICALS A/S
CHR. OLESEN PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Christian Dam Olesen, Mads Christian Olesen and Phillip Christian Dam Quitzau Olesen. The board consists of Tobias Facklam (chair), Christian Dam Olesen and Fabian von Volkmann. The company is owned by CHR. OLESEN A/S and SVVF UG & Co. KG. The company has 2 employees (2026). In 2025, the company reported a gross profit of EUR 1,210,782 and a net result of EUR 237,447 compared with EUR 70,556 the year before. Equity in the 2025 report amounted to EUR 1,744,707.
